BNGO MEX Week ended 31 Jul 2026

Weekly Investor Report

Name: BNGO weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

Bionano Genomics, Inc. · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data

Latest close 19.09 MXN

-4.6% latest week

Weekly setup

Weak trend

The weekly trend is not active. Price is -11.7% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned -4.6%, after a -4.5% four-week move. The latest news-sentiment score is 49/100.

Setup score 25 out of 100

Latest Close 19.09 MXN 31 Jul 2026

1W Return -4.6% latest completed week

4W Return -4.5% short-term follow-through

12W Return -16.9% quarterly tape

Trend Breadth 0.0% 0 of 52 weeks active

Volume Ratio 1.5x vs 13-week average

What is working

Activity pressure is positive on the latest completed week.

What could go wrong

The trend backdrop is inactive, so price action has not confirmed a constructive regime.
Price is below the Trend Line, which keeps downside pressure in focus.
Price is below Fair Value, so the market is still discounting the latest tape.
Next-week expectancy is negative at 31.56% based on similar historical setup states.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through -4.6% Latest completed week; four-week move -4.5%. Indicator stack 0/50 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 31.56% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 49/100 19 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -11.7% below the Trend Line and sits at 0.1% of its 52-week range. The latest completed week returned -4.6%, after a -4.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

19.00 MXN 0.1% 93.96 MXN

Range location0.1%Shows where the latest close sits between the 52-week low and high.

Trend distance-11.7%Price premium or discount versus the weekly Trend Line.

Fair-value gap-97.0%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-79.7%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.5x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0612-week average 0.13

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.06Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.5% over four weeks, -16.9% over 12 weeks, and -65.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.6%

4W-4.5%

12W-16.9%

26W-20.5%

52W-65.9%

Active trend streak0 weeks

Active weeks in one year0

Trend breadth0.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.36Latest activity-pressure read.

Pressure change-76.8%Four-week change in activity pressure.

Leadership-38.21Latest relative-leadership reading.

RS change12.3%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment49/100

Weighted news tone is neutral across 19 relevant articles.

4 positive · 13 neutral · 2 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-79.7%Distance below the 52-week high.

13-week volatility5.3%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher9 of 2616 weeks finished lower.

Best week+15.1%Week of 17 Apr.

Worst week-12.0%Week of 13 Feb.

Latest week-4.6%Week of 31 Jul.

Shape of recent returns

Strong gains5

Modest gains4

Flat weeks1

Modest losses10

Sharp losses6

Recent vol5.3%13-week weekly-return volatility.

Base vol10.3%52-week weekly-return volatility.

Up/down split20/28Count of positive and negative weeks in the 52-week window.

Average skew6.4% / -7.1%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorMX Healthcare

4-week rank59 / 78

Group average-1.0%

Trend breadth28.2%

Trend28.2%active weekly trend signals

MD62.8%positive activity pressure

RS35.9%positive relative leadership

Four-week leaders

IQV · MEX23.0%INCY · MEX21.5%ILMN · MEX20.5%BAYNN · MEX17.1%TDOC · MEX15.8%

IndustryMX Medical Instruments & Supplies

4-week rank4 / 5

Group average-3.0%

Trend breadth0.0%

Trend0.0%active weekly trend signals

MD80.0%positive activity pressure

RS0.0%positive relative leadership

Four-week leaders

COO · MEX7.0%BDX · MEX0.0%SOLV · MEX0.0%BNGO · MEX-4.5%ISRG · MEX-17.5%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

Indicator analysis30/100

Latest 12-week confirmation: trend 0/12, activity pressure 12/12, relative leadership 0/12.

Activity pressure 0.06; No reversal markers Next-Week ExpectancyNegative 31.56%

Next-week expectancy is negative with a 31.56% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment49/100

Weighted news tone is neutral across 19 relevant articles.

Bionano Genomics (BNGO) CSO reports holding 63 shares Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	19.09 MXN	-4.6%	21.63 MXN	626.2 MXN	0.36	-38.21	250	Off
24 Jul 2026	20.00 MXN	-0.4%	21.91 MXN	658.0 MXN	0.65	-36.57	130	Off
17 Jul 2026	20.09 MXN	0.0%	22.17 MXN	695.7 MXN	1.01	-38.78	0	Off
10 Jul 2026	20.09 MXN	0.5%	22.53 MXN	734.8 MXN	1.30	-40.80	12	Off
3 Jul 2026	19.99 MXN	0.4%	22.88 MXN	777.2 MXN	1.56	-43.55	256	Off
26 Jun 2026	19.92 MXN	-1.4%	23.25 MXN	815.9 MXN	1.71	-45.67	100	Off
19 Jun 2026	20.20 MXN	-1.9%	23.58 MXN	856.6 MXN	1.80	-47.00	0	Off
12 Jun 2026	20.60 MXN	-7.6%	23.86 MXN	898.3 MXN	1.90	-47.81	9	Off
5 Jun 2026	22.30 MXN	-3.0%	24.18 MXN	947.3 MXN	2.03	-43.64	0	Off
29 May 2026	23.00 MXN	7.0%	24.40 MXN	996.6 MXN	1.98	-45.52	199	Off
22 May 2026	21.50 MXN	4.9%	24.80 MXN	1,052 MXN	1.74	-50.29	345	Off
15 May 2026	20.50 MXN	-10.8%	25.25 MXN	1,098 MXN	1.48	-53.77	926	Off
8 May 2026	22.98 MXN	9.4%	25.80 MXN	1,145 MXN	1.16	-51.07	5	Off
1 May 2026	21.00 MXN	-1.9%	26.34 MXN	1,192 MXN	0.87	-55.20	245	Off

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.